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Natural polyunsaturated fatty acids (PUFA) were synthesized and assessed as potential
anti-inflammatory agents. B-oxa, B-thia and y-thia PUFA were found to inhibit T lymphocyte
responses in vitro, assessed as lymphoproliferation as well as production of tumour necrosis
factor-B (llNFP), interferon-y (IFNY) and interleúkin-2 (IL-2). Threee of these compounds were
studied in detail and found to be more active than the inhibition seen with fish oil fatty acid
22:6n-3. Interestingly these compounds unlike 22:6n-3 were poor stimulators of the human
neutrophil respiratory burst, an additional advantage in their use as anti-inflammatory agents.
Examination of one of these three, p-oxa 2I:3n-3, in in vivo models of chronic and acute
inflammation showed that the fatty acids was highly inhibitory in both types of inflammatory
responses. Thus the B-oxa 27:3n-3 inhibited the footpad swelling induced by sheep red blood
cell antigens in a delayed type hypersensitivity (DTH) reaction as well as in the caffageenan-
induced paw inflammation. This finding with DTH which is dependent on T lymphocytes is
consistent with the ability of p-oxa 2l:3n-3 to inhibit Thl type cytokine production. While the
reason for its effects on the caÍageenan induced inflammation are less clea¡ in this involves
predominantly neutrophil infiltration, this reaction also has some T cell dependency. Studies on
tissue distribution of the fatty acid, showed that B-oxa 2I:3n-3 was incorporated into membrane
phospholipids of liver and blood cells. Preliminary toxicology studies also demonstrated that B-
oxa2l:3n-3 was well tolerated by the animals as several chemical and biochemical parameters of
liver and kidney function remained within the normal range.
The mechanism of inhibition of T lymphocyte responses were in the main identified. The
B-oxa 2l:3n-3 acted at a post receptor level affecting signals modules critical for lymphocyte
)0Õ/l
activation and cytokine production. The fatty acid caused inhibition of pHA-pMA induced
translocation of PKC-BI and PKC-e, but not PKC-cr, PKC-BII or pKC-o. This was further
delineated to show inhibition of downstream ERK pathway activation but not the JNK or p3g
pathways.
This work has identified a new class of anti-inflammatory compounds which are based on
PUFA. The action of the fatty acids is through the selective inhibition of the pKC-Bl/e and
ERK signalling module.
